How psychological safety influences workplace injury prevention and offers strategies for safety professionals to foster more ...

The National Safety Council is urging construction employers and safety professionals nationwide to participate in the 2025 ...

Q1 2025 Earnings Call Transcript May 13, 2025 Acumen Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Interim data from ENERGY 3 trial highlight INZ-701's potential to modify disease course in ENPP1 Deficiency, with sustained ...

Q1 2025 Earnings Call Transcript May 12, 2025 Xenon Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.83, ...

“We urge all employers, regardless of size or industry, to join this important ... training Ladder safety guides and tip sheets Work to Zero educational videos and webinars Data tools to aid ...

Pivotal Phase 3 LUCIDITY trial of avexitide, a potential first-in-class GLP-1 receptor antagonist with FDA breakthrough therapy designation, underway in post-bariatric hypoglycemia (PBH); completion ...

Atea defines working capital as current assets less current liabilities. See the Company's condensed consolidated financial ...

Credicorp's BCP leads Peru's banking sector with strong ROE, leveraging market share and low-cost deposits. See an analysis ...

The company will celebrate on social media, sharing patient and provider stories that highlight the impact NeuroStar has as a safe, effective, and non-drug treatment for depression "National TMS ...

NEW YORK and BERLIN, May 14, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective ...

Welcome to the Legend Biotech’s First Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer ...